| Heart disease and stroke statistics—2017 update: a report from the American Heart Association EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... circulation 135 (10), e146-e603, 2017 | 57103* | 2017 |
| Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome PM Vespa, K O’phelan, M Shah, J Mirabelli, S Starkman, C Kidwell, ... Neurology 60 (9), 1441-1446, 2003 | 680 | 2003 |
| Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis YY Janjigian, D Werner, C Pauligk, K Steinmetz, DP Kelsen, E Jäger, ... Annals of oncology 23 (10), 2656-2662, 2012 | 378 | 2012 |
| The general principles of Avicenna's Canon of Medicine MH Shah Naveed Clinic, 1966 | 234 | 1966 |
| Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridum difficile infection – fresh, or frozen, or lyophilised microbiota from a small pool of … ZD Jiang, NJ Ajami, JF Petrosino, G Jun, CL Hanis, M Shah, L Hochman, ... Alimentary Pharmacology & Therapeutics 45 (7), 899-908, 2017 | 197 | 2017 |
| Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases B Brenner, MA Shah, M Gonen, DS Klimstra, J Shia, DP Kelsen British journal of cancer 90 (9), 1720-1726, 2004 | 181 | 2004 |
| AVAGAST: A randomized, double-blind, placebo-controlled, phase III study of first-line capecitabine and cisplatin plus bevacizumab or placebo in patients with advanced gastric … Y Kang, A Ohtsu, E Van Cutsem, SY Rha, A Sawaki, S Park, H Lim, J Wu, ... Journal of Clinical oncology 28 (18_suppl), LBA4007-LBA4007, 2010 | 170 | 2010 |
| LBA8_PR Pembrolizumab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced esophageal cancer: The phase 3 KEYNOTE-590 study K Kato, JM Sun, MA Shah, PC Enzinger, A Adenis, T Doi, T Kojima, ... Annals of Oncology 31, S1192-S1193, 2020 | 169 | 2020 |
| Metal oxide catalysts for lean NOx reduction KA Bethke, MC Kung, B Yang, M Shah, D Alt, C Li, HH Kung Catalysis Today 26 (2), 169-183, 1995 | 153 | 1995 |
| Principles of nanoscience and nanotechnology MA Shah, T Ahmad Alpha Science International, 2010 | 119 | 2010 |
| Is ‘chemo-fog’/‘chemo-brain’caused by cancer chemotherapy? RB Raffa, PV Duong, J Finney, DA Garber, LM Lam, SS Mathew, NN Patel, ... Journal of Clinical Pharmacy & Therapeutics 31 (2), 2006 | 115 | 2006 |
| Microwave absorption by water in building materials JB Hasted, MA Shah British Journal of Applied Physics 15 (7), 825, 1964 | 103 | 1964 |
| Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors MN Fornier, D Rathkopf, M Shah, S Patil, E O'Reilly, AN Tse, C Hudis, ... Clinical cancer research 13 (19), 5841-5846, 2007 | 102 | 2007 |
| North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Endoscopy Committee. Management of ingested foreign bodies in children: a clinical report of … RE Kramer, DG Lerner, T Lin, M Manfredi, M Shah, TC Stephen, ... J Pediatr Gastroenterol Nutr 60 (4), 562-74, 2015 | 92 | 2015 |
| Effective treatment systems for azo dye degradation: a joint venture between physico-chemical & microbiological process M Shah International Journal of Environmental Bioremediation & Biodegradation 2 (5 …, 2014 | 82 | 2014 |
| A phase II trial of neoadjuvant cisplatin–fluorouracil followed by postoperative intraperitoneal floxuridine–leucovorin in patients with locally advanced gastric cancer B Brenner, MA Shah, MS Karpeh, M Gonen, MF Brennan, DG Coit, ... Annals of oncology 17 (9), 1404-1411, 2006 | 81 | 2006 |
| Socio-technical factors affecting ERP implementation success in Pakistan: an empirical study SIH Shah, RH Bokhari, S Hassan, MH Shah, MA Shah Australian Journal of Basic and Applied Sciences 5 (3), 742-749, 2011 | 79 | 2011 |
| Sub-acute toxicity studies on pendimethalin in rats MAA SHAH, SK Garg, KM Garg Indian Journal of Pharmacology 29 (5), 322-324, 1997 | 76 | 1997 |
| Application of ridge regression to multicollinear data GR Pasha, MA Shah Journal of research (Science) 15 (1), 97-106, 2004 | 73 | 2004 |
| Pertuzumab (P)+ trastuzumab (H)+ chemotherapy (CT) for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (mGC/GEJC): final analysis of a phase III study … J Tabernero, PM Hoff, L Shen, A Ohtsu, MA Shah, K Cheng, C Song, ... Annals of Oncology 28, v209, 2017 | 68 | 2017 |
Atif KhanComputer Science, University of WaterlooVerified email at uwaterloo.ca
